The European e-pharmacy market is scaling rapidly in 2026 and moving towards a market volume of more than €70 billion. In this environment of intensive digital transformation, international medicine retailers, investors and retail groups must design logistics and regulatory structures for both efficiency and compliance.
The strategic question is no longer simply whether cross-border expansion makes sense, but which hub can manage the European supply chain most reliably. Traditional western European locations such as the Netherlands face rising cost structures and, in some projects, lengthy authority coordination. Czechia has therefore become an increasingly important option for modern online pharmacies. A scalable cross-border model still requires careful interpretation of EU and national medicines law rather than a simple search for the least restrictive jurisdiction.
Czech authorities can offer a comparatively predictable framework for implementing European requirements. A consistent approval environment can reduce transaction and governance costs during market entry and improve planning. At the same time, an operator must assess which products may be supplied to which country, which pharmacy and wholesale authorisations are required and how patient, prescription and pharmacovigilance duties are met.
Czechia’s central position can support efficient access to Germany, Austria and other European markets. A hub in a western Czech border region such as Cheb can shorten transport routes to the DACH market and improve last-mile lead times. The location decision should nevertheless include carrier networks, validated temperature corridors, customs and tax processes, language requirements, delivery promises and contingency routes.
The labour market is another relevant factor. Compared with some western European logistics markets, Czechia can offer access to qualified, multilingual staff in pharmacy, IT and logistics. Stable teams help retain sensitive GxP process knowledge and reduce the cost of repeated recruitment and retraining.
A Czech e-pharmacy hub is therefore not merely a low-cost location. Its value depends on a coherent combination of licensing, QMS, GDP logistics, technology, staffing and target-market compliance. tiger.PHARMA supports feasibility analysis, location planning and regulatory-operational implementation.
Contact us for a detailed discussion of location and regulatory requirements.